Gentian Diagnostics ASA — Director's Dealing 2025

May 23, 2025

Disclosure of shareholding

Disclosure of shareholding

Viola AS, a wholly-owned subsidiary of Rasmussengruppen AS, sold 50,000 shares in Gentian Diagnostics ASA (the "Company") on 23 May 2025 with settlement on 27 May 2025.

As a result of the transaction, companies wholly-owned by Rasmussengruppen AS decreased their consolidated holding of shares in the Company from 793,421 to 743,421 shares, equal to a decrease from approximately 5.14% to approximately 4.82% of the votes and shares in the Company. The shares are held by Viola AS (208,421 shares), Portia AS (300,000 shares) and Cressida AS (235,000 shares).

The above mentioned companies have no other rights to shares issued by the Company.

This announcement is made in accordance with Section 4-2 of the Norwegian Securities Trading Act.